Pana+Care
PrivateLast Round
SAFE
Dec 1, 2025
Total Funding Raised
$10,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pana+Care is a healthtech company that provides a structured, continuous chronic care management platform for patients with diabetes and hypertension in Kenya.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pana+Care Comparables
Compare Pana+Care with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Baobab Circle | 82% | |
| Medtronic | 77% | |
| Antara Health | 70% | |
Pana+Care Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SAFE | Dec 1, 2025 |
Pana+Care Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Villgro Africa | SAFE |
| Health Innovation Hub (H2i) @ U of T | SAFE |
| African Impact Initiative | SAFE |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2025
$10K round led by African Impact Initiative.
Pana+Care Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pana+Care's valuation, stock price, and market status.